Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Minimally differentiated acute leukemia

F J Cadwell1, C P Burns, F R Dick

  • 1Department of Medicine, University of Iowa College of Medicine, Iowa City 52242.

Leukemia Research
|March 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of Anxiety and Depression on the Interplay Between Disorders of Gut-Brain Interaction and Eating Disorders.

Clinical and translational gastroenterology·2026
Same author

Evidence for Brain-To-Gut and Gut-To-Brain Pathways in Primary Care Patients With Disorders of Gut-Brain Interaction, Inflammatory Bowel Disease and Gastroesophageal Reflux Disease.

Neurogastroenterology and motility·2025
Same author

Navigating the Maze of Functional Dyspepsia: Emergence of a New Entity, Postprandial Epigastric Pain Syndrome.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2025
Same author

Response to Kanaujia et al.

The Journal of hospital infection·2024
Same author

Comparison of two endoscope channel cleaning approaches to remove cyclic build-up biofilm.

The Journal of hospital infection·2024
Same author

Variation in General Dentists' Patterns of Sealant Use in Children with Elevated Caries Risk.

JDR clinical and translational research·2022
Same journal

A multicenter real-world study of clinical outcomes in octogenarians and older patients with acute myeloid leukemia.

Leukemia research·2026
Same journal

FLAMSA versus FLAG-IDA as salvage therapy in adults with relapsed/refractory acute myeloid leukemia and acute lymphoblastic leukemia: A single-center real-world retrospective study.

Leukemia research·2026
Same journal

CD244 modulates bone marrow infiltrating CD8<sup>+</sup> T cells and serves as a prognostic and immunotherapeutic target in acute myeloid leukemia.

Leukemia research·2026
Same journal

Long-term remission and survival in older adults with IDH-mutated acute myeloid leukemia treated with IDH inhibitors.

Leukemia research·2026
Same journal

Real-world outcomes of plasmablastic lymphoma: Treatment approaches and survival outcomes in the PLASMABLAT-001 cohort.

Leukemia research·2026
Same journal

CRS and ICANS as class-level adverse event for CD20 ×CD3 bispecific T-cell engagers: A Bayesian analysis of a nationwide database.

Leukemia research·2026
See all related articles

Minimally differentiated acute leukemia (MD-AL) presents unique features and a poor prognosis. Patients with MD-AL show lower remission rates, suggesting novel treatment strategies are needed.

Area of Science:

  • Hematology
  • Oncology
  • Leukemia Research

Background:

  • Acute myeloid leukemia (AML) classification can be challenging, particularly for undifferentiated subtypes.
  • Minimally differentiated acute leukemia (MD-AL) is a morphologically distinct entity within AML.
  • Understanding MD-AL's characteristics is crucial for improving patient outcomes.

Purpose of the Study:

  • To characterize the clinical features and outcomes of minimally differentiated acute leukemia (MD-AL).
  • To compare MD-AL patients with other subtypes of acute myeloid leukemia (FAB M1-M7).
  • To evaluate the efficacy of different induction therapy regimens in MD-AL.

Main Methods:

  • Retrospective analysis of 35 adult patients diagnosed with MD-AL.
  • Comparison with patients diagnosed with FAB M1-M7 acute myeloid leukemia.

Related Experiment Videos

  • Immunophenotyping of leukemic blast cells in a subset of patients.
  • Analysis of treatment outcomes based on induction therapy regimens.

    • Main Results:

    • MD-AL patients exhibited distinct presenting features: higher incidence of prior hematologic disease, lower WBC, fewer blasts, lower marrow cellularity, and older age.
    • Complete remission rates were significantly lower in MD-AL patients (35%) compared to other AML subtypes (64%, p=0.03).
    • Treatment failure was primarily due to resistant disease; regimens including vincristine and prednisone showed a potential advantage.

    Conclusions:

    • MD-AL represents a distinct entity within acute myeloid leukemia with characteristic features and a poor response rate to conventional therapy.
    • Vincristine and prednisone-containing regimens warrant inclusion in experimental induction programs for MD-AL.
    • Further research and refined diagnostic criteria are needed for optimal management of MD-AL.